此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity (GET FIT)

2020年11月12日 更新者:University of California, Los Angeles
This project is prompted by the urgent public health need to identify novel strategies to prevent cardiovascular disease (CVD) and type 2 diabetes (T2D). The higher prevalence of CVD, T2D, and metabolic syndrome in obese individuals is a major healthcare concern. Therefore, finding optimal intervention strategies to combat these growing epidemics is imperative.

研究概览

详细说明

At present, the extent to which dietary components can modify endothelial function, monocyte inflammation and glycemic variations is not well defined, although different carbohydrates are known to vary in their abilities to induce plasma glucose and insulin responses. Epidemiologic work suggests that high dietary glycemic load (GL) is associated with increased concentrations of inflammatory cytokines, endothelial dysfunction markers, and increased risk of T2D and coronary heart disease (CHD). We are examining using randomized control trials low vs. high-GL diet to determine if low-GL diets induce improvements in endothelial function or monocyte inflammation. Furthermore, resistance training is an alternate form of exercise from conventional aerobic training. Resistance Training has the potential to improve endothelial function or monocyte phenotype, but there is very little data in this area. We hypothesize that resistance training may augment the beneficial effects of a low-GL diet in improving metabolic health.

研究类型

介入性

注册 (实际的)

88

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • California
      • Los Angeles、California、美国、90095
        • University of California, Los Angeles

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 35年 (成人)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • 18-35 with BMI≥30 and/or your waist circumference ≥40 inches for males or ≥35 inches for females
  • In good health as determined by the screening visit and review of medical history

Exclusion Criteria:

  • Have a known heart arrhythmia and/or abnormalities found in electrocardiogram (ECG) reading or use of medications that influence CV function
  • Have been in a weight loss or exercise program in the 6 months prior to participation
  • Use tobacco products
  • Have a syndrome or are prescribed medications that may influence body composition, insulin action, or CVD (e.g. PCOS, prednisone, methylphenidate, etc.)
  • Have intolerance to lactose or gluten
  • Pregnant

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:阶乘赋值
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Low Glycemic Load + Resistance Training
12-week intervention diet + resistance training (1 hour, 3 times per week)
实验性的:High Glycemic Load + Resistance Training
12-week control diet + resistance training (1 hour, 3 times per week)
实验性的:Low Glycemic Load
12-week intervention diet
其他:High Glycemic Load
12-week control diet

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Endothelial function as determined by brachial artery FMD
大体时间:12 weeks
12 weeks

次要结果测量

结果测量
大体时间
monocyte inflammation
大体时间:12 weeks
12 weeks
Insulin Sensitivity by Oral Glucose Tolerance Test
大体时间:12 weeks
12 weeks
MAGE via Continuous Glucose Monitoring System
大体时间:12 weeks
12 weeks

其他结果措施

结果测量
措施说明
大体时间
body composition (total fat mass, visceral fat, HFF, LBM) via DXA and MRI
大体时间:12 weeks
12 weeks
plasma and cellular biomarkers post pre and post 12 week intervention
大体时间:12 weeks

Monocytes will be isolated from subject whole blood and will be phenotyped in 2 ways: 1) as pro- or anti-inflammatory based on flow-activated cell sorting (FACS) analysis of monocyte-specific markers TLR-4, CD14 and CD16.

Serum-Stimulated Cell Culture. Subject serum will be incubated with L6 cells as we have previously performed in monocytes and adipocytes as well as endothelial cells 18, 130. Following 48 hr incubation, cellular insulin-stimulated glucose transport will be assayed as described 129 and conditioned medium assayed for myokine levels (ex. IL-15, 1L-6, etc).

Fasting plasma (and conditioned media where appropriate) will be taken to determine a panel of adipokines and hormones (e.g. insulin, adiponectin, HSP-72, IL-4, IL-6, IL-10, MCP-1, CRP, 8-iso PGF2α) will be measured using the Millipore Multiplex assay kit or with specific ELISA kits

12 weeks
RNA/protein levels via muscle and fat tissue collection
大体时间:12 weeks
Approximately 300 mg of muscle tissue from the superficial portion of the vastus lateralis and approximately 3-5 g of subcutaneous adipose tissue from the periumbilical portion of the abdomen will be obtained.
12 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Catherine Carpenter, PhD, MPH、University of California, Los Angeles

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2012年4月1日

初级完成 (实际的)

2017年12月14日

研究完成 (实际的)

2017年12月14日

研究注册日期

首次提交

2012年10月11日

首先提交符合 QC 标准的

2012年12月19日

首次发布 (估计)

2012年12月24日

研究记录更新

最后更新发布 (实际的)

2020年11月16日

上次提交的符合 QC 标准的更新

2020年11月12日

最后验证

2020年11月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅